Proteomic Analysis of the Cerebrospinal Fluid of Parkinson's Disease Patients Pre- and Post-Deep Brain Stimulation

被引:20
作者
Wang, Er-Song [1 ,2 ]
Yao, Hui-Bin [1 ]
Chen, Ying-Hui [3 ]
Wang, Gan [2 ]
Gao, Wen-Wei [2 ]
Sun, Yi-Rui [4 ,5 ]
Guo, Ji-Guang [6 ]
Hu, Jian-Wen [7 ]
Jiang, Cheng-Chuan [1 ,4 ,5 ]
Hu, Jin [1 ,4 ,5 ]
机构
[1] Fudan Univ, Jinshan Hosp, Dept Neurosurg, Shanghai 201508, Peoples R China
[2] Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 6, Dept Neurosurg, Shanghai, Peoples R China
[3] Fudan Univ, Jinshan Hosp, Dept Neurol, Shanghai 200433, Peoples R China
[4] Fudan Univ, Huashan Hosp, Dept Neurosurg, Shanghai 200433, Peoples R China
[5] Shanghai Neurosurg Ctr, Shanghai, Peoples R China
[6] Chinese Acad Sci, Shanghai Inst Neurosci, Shanghai, Peoples R China
[7] Chinese Acad Sci, Shanghai Inst Biol Sci, Res Ctr Proteome Anal, Shanghai, Peoples R China
关键词
Cerebrospinal fluid; Deep brain stimulation; Parkinson's disease; Proteomics; EXTRACELLULAR-SUPEROXIDE DISMUTASE; APOLIPOPROTEIN-A-I; PROTEIN AGGREGATION; TETRANECTIN; EXPRESSION; PATHOGENESIS; INSIGHTS; SYSTEM;
D O I
10.1159/000350082
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Aims: To investigate alterations in protein expression associated with deep brain stimulation (DBS) in an attempt to elucidate possible mechanisms of action. Methods: Crebrospinal fluid (CSF), obtained from six Parkinson's disease (PD) patients (pre- and post-DBS) and from six normal healthy controls, was studied for differentially expressed proteins. 2-D DIGE, in combination with MALDI-TOF and TOF-TOF Mass Spectrometry (MS) or ESI-MS, was used to identify the changed proteins (3 PD patients and 3 controls). Selected proteins were further studied using western blotting (6 PD patients and 6 controls). Results: Twenty-one proteins were identified after MS and protein database interrogation. Apart from apolipoprotein A-I (apoA-I), the expression levels of complement C4 (C4), IgA, tetranectin, and extracellular superoxide dismutase (EC-SOD), detected by western blotting, correlated well with the 2-D DIGE results. In the follow-up period, the expression levels of C4, apoA-I and IgA were stable whereas EC-SOD and tetranectin were significantly elevated. In addition, when DBS was ceased in one patient due to a suicide attempt, the levels of EC-SOD and tetranectin significantly decreased. Conclusion: Our preliminary results suggest that variations in the expression levels of EC-SOD and tetranectin in CSF is related to DBS. Copyright (C) 2013 S. Karger AG, Basel.
引用
收藏
页码:625 / 637
页数:13
相关论文
共 32 条
[1]   Protein misfolding in neurodegenerative diseases [J].
Agorogiannis, EI ;
Agorogiannis, GI ;
Papadimitriou, A ;
Hadjigeorgiou, GM .
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 2004, 30 (03) :215-224
[2]   A novel experimental design for comparative two-dimensional gel analysis: Two-dimensional difference gel electrophoresis incorporating a pooled internal standard [J].
Alban, A ;
David, SO ;
Bjorkesten, L ;
Andersson, C ;
Sloge, E ;
Lewis, S ;
Currie, I .
PROTEOMICS, 2003, 3 (01) :36-44
[3]   Therapeutic electrical stimulation of the central nervous system [J].
Benabid, AL ;
Wallace, B ;
Mitrofanis, J ;
Xia, C ;
Piallat, B ;
Fraix, V ;
Batir, A ;
Krack, P ;
Pollak, P ;
Berger, F .
COMPTES RENDUS BIOLOGIES, 2005, 328 (02) :177-186
[4]   Deep brain stimulation for Parkinson's disease [J].
Benabid, AL .
CURRENT OPINION IN NEUROBIOLOGY, 2003, 13 (06) :696-706
[5]   Subthalamic stimulation for Parkinson's disease [J].
Benabid, AL ;
Koudsié, A ;
Benazzouz, A ;
Fraix, V ;
Ashraf, A ;
Le Bas, JF ;
Chabardes, S ;
Pollak, P .
ARCHIVES OF MEDICAL RESEARCH, 2000, 31 (03) :282-289
[6]   Deep brain stimulation of the subthalamic nucleus for the treatment of Parkinson's disease [J].
Benabid, Alim Louis ;
Chabardes, Stephan ;
Mitrofanis, John ;
Pollak, Pierre .
LANCET NEUROLOGY, 2009, 8 (01) :67-81
[7]   On the adaptive control of the false discovery fate in multiple testing with independent statistics [J].
Benjamini, Y ;
Hochberg, Y .
JOURNAL OF EDUCATIONAL AND BEHAVIORAL STATISTICS, 2000, 25 (01) :60-83
[8]   The use of proteomics in biomarker discovery in neurodegenerative diseases [J].
Davidsson, P ;
Sjögren, M .
DISEASE MARKERS, 2005, 21 (02) :81-92
[9]  
Davidsson P, 2001, PROTEOMICS, V1, P444
[10]   Expression of the plasminogen activator system and the inhibitors PAI-1 and PAI-2 in posttraumatic lesions of the CNS and brain injuries following dramatic circulatory arrests: An immunohistochemical study [J].
Dietzmann, K ;
von Bossanyi, P ;
Krause, D ;
Wittig, H ;
Mawrin, C ;
Kirches, E .
PATHOLOGY RESEARCH AND PRACTICE, 2000, 196 (01) :15-21